28 January 2026 : Clinical Research
Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkish Oncology Centers
Halil Göksel Güzel
ABCDEF 1*, Arif Hakan Önder ABDEF 1, Yusuf İlhan BD 2, Onur Yazdan Balçık BD 3, Banu Öztürk ABEF 1
DOI: 10.12659/MSM.951027
Med Sci Monit 2026; 32:e951027
Figure 3 Distribution of clinical trials in hospitals in the 3 largest metropolitan areas and other cities. (A) Ongoing trials:The median number of ongoing clinical trials conducted in hospitals within the largest metropolitan areas was significantly greater than that in other cities: 2 (0–50) and 0 (0–25), respectively; P=0.002. (B) Clinical trials actively recruiting: Similarly, the median number of clinical trials actively recruiting patients was significantly higher in the largest metropolitan areas than in other cities: 2 (0–42) and 0 (0–25), respectively; P=0.008.